Recombinant Canine Interleukin-8/CXCL8 (Canine IL-8/CXCL8)_C230270 Epidermal Growth Factor (EGF) In contrast

In contrast

Accession #Q9UPY5: Met1 - Leu501

High Safety: No LDEV (lactate dehydrogenase elevating virus)

Component Number Component Name Storage Temperature P162004S P162004E P162004-A ELISA Plate 2~8℃ 48 T 96 T P162004-B Standard 2~8℃ 1 tube 2 tubes P162004-C Detection Antibody 2~8℃ 120 μL 240 μL P162004-D Enzyme Conjugate 2~8℃(Avoid Light) 30 μL 60 μL P162004-E Sample Dilution Buffer 2~8℃ 8 mL 15 mL P162004-F Antibody/Enzyme Dilution Buffer 2~8℃ 15 mL 30 mL P162004-G 20x Wash Buffer 2~8℃ 25 mL 50 mL P162004-H Substrate Solution 2~8℃(Avoid Light) 8 mL 15 mL P162004-I Stop Solution Room Temperature 5 mL 10 mL P162004-J Plate Sealant Film Room Temperature 3 pieces 5 pieces

Fully biologically active when compared to standard

Recombinant Canine Interleukin-8/CXCL8 (Canine IL-8/CXCL8)_C230270 Epidermal Growth Factor (EGF) In contrastInterleukin 8 (IL 8), also known as CXCL8, GCP 1, and NAP 1, is a widely expressed proinflammatory member of the CXC family of chemokines. Near its N terminus, this 8 9 kDa chemokine contains an ELR motif which is important for its angiogenic properties. CXCL8 can associate into a homodimer or a heterodimer with CXCL4 PF4, and it can also interact with matrix and cell surface glycosaminoglycans. Mature canine CXCL8 shares 87%, 69%, and 82% amino acid